市場調査レポート
商品コード
1410774
人工硬膜市場:セグメント別規模、シェア、法規制、償還、手技、2033年までの予測Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
人工硬膜市場:セグメント別規模、シェア、法規制、償還、手技、2033年までの予測 |
出版日: 2023年12月20日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
人工硬膜は、硬膜を修復する際にシートや材料として使用されるパッチです。硬膜の閉鎖や修復は、脳脊髄液(CSF)漏れを防ぐために不可欠です。
生物学的人工硬膜は、血管と上皮の融合を起こす能力があり、本来の硬膜と一体化するのに役立ちます。この種の代用硬膜は、すべての細胞や抗原が除去され、病気感染の可能性がないように加工されます。このような理由から、神経血管外科医は合成人工硬膜よりも生物学的人工硬膜の使用を好みます。生物学的代用硬膜は引っ張り強度に優れているため、移植後のパッチが安定します。
当レポートは、世界の人工硬膜市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Dura Substitutes market for the year 2020 and beyond. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a Cerebrospinal Fluid (CSF) Leak.
The model considers two types of dura substitutes, biological and synthetic. Biological dura substitutes have the ability to undergo vascular and epithelial fusion which helps them to integrate with the native dura mater. This type of substitute is processed so that all cells and antigens are removed and chances of disease transmission is nil. For this reason, neurovascular surgeons prefer using biological dura substitutes over synthetic dura substitutes. The latter have good tensile strength which provides stability to the patch after implantation.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dura Substitutes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable